On Biostatistics and Clinical Trials: SAD and MAD: Single Ascending Dose and Multiple Ascending Dose first-in-human studies
A first-in-human study to investigate the safety, tolerability, pharma | DDDT
STATISTICAL ANALYSIS PLAN Protocol PQ-010-001 PHASE 1B, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, DOSE ESCALATION STUDY TO
Types of Study in Early Clinical Development - EUPATI Toolbox
Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers | Antimicrobial ...
Traditional Process First in Human Single Ascending Dose Multiple Ascending Dose U.S.A. Japan Phase II Phase III NDA in Japan Phase II Phase III NDA in. - ppt download
Frontiers | Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial
Single and multiple ascending dose GS-9256 and GS-9451 clinical trial... | Download Scientific Diagram
On Biostatistics and Clinical Trials: SAD and MAD: Single Ascending Dose and Multiple Ascending Dose first-in-human studies
Planning Your (First) First-in Human Trial? Considerations for Success - Xtalks
Single Ascending Dose & Multiple Ascending Dose
Study design with overlapping SAD-MAD cohorts, where treatment periods... | Download Scientific Diagram
A Flow-chart of the single-ascending-dose (SAD) and... | Download Scientific Diagram
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects | SpringerLink
A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers - Hazan - 2020 - Clinical Pharmacology in Drug Development - Wiley Online Library
A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary
JCI - Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age - ScienceDirect
Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies | SpringerLink
Planning Your (First) First-in Human Trial? Considerations for Success - Xtalks
Statistical considerations in exploratory studies
Phase I: Overview
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis | Gut
Safety, tolerability, and pharmacokinetics of TPN171H - DDDT | DDDT
